Yang Guang, Chen Shu, Cui Jin-huan, Si Jian-hua, Tan Jia-ju
Institute of Medical Researches, the First People's Hospital of Foshan, Foshan 528000, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Jun;26(6):440-3.
Using polymerase chain reaction-reverse blot dot (PCR-RDB) technique to establish a new method for hepatitis C virus (HCV) genotyping and to study the distribution of HCV genotypes in Foshan area.
HCV primers and probes were designed in 5'-untranslated region (nt-1-nt-299) of HCV. HCV RNA in serum was isolated and purified, and its cDNA was obtained by reversed transcription. Nested PCR using biotin-labelled primers, was done. PCR products were hybridized with immobilized specific probes (genotype 1a to 3b) on Biodyne C membrane to genotype HCV by color development while adding POD and TMB. A certain judgment could be made according to the position of color reaction. The reliability of this new method was verified by sequencing. HCV RNA levels in serum were determined by real time fluorescent quantitative (FQ)-PCR. 60 FQ-PCR-positive HCV sera from Foshan area were genotyped using this assay.
All 60 sera could be successfully genotyped by PCR-RBD. 50 (83.3%) cases were found to be genotype 1b, 2 (3.3%) as genotype 1a and 2 (3.3%) as genotype 2a while 5 (8.0%) to be mixture of genotype 1a and 1b, and 1 (1.7%) to be mixture of genotypes 1b and 2a. No genotypes 2b, 3a and 3b were found. The results of PCR-RDB genotyping methods coincided with sequence analysis.
Newly established HCV genotyping system was proved to be sensitive, specific, precise and economic, thus suitable for clinical and epidemiologic studies. The results of HCV genotyping showed that genotype 1b was the predominant genotype in Foshan area.
应用聚合酶链反应-反向斑点杂交技术(PCR-RDB)建立丙型肝炎病毒(HCV)基因分型新方法,并研究佛山地区HCV基因分型的分布情况。
在HCV的5'非编码区(nt-1至nt-299)设计HCV引物和探针。分离纯化血清中的HCV RNA,经逆转录获得其cDNA。采用生物素标记引物进行巢式PCR。PCR产物与固定在Biodyne C膜上的特异性探针(基因型1a至3b)杂交,加入辣根过氧化物酶(POD)和四甲基联苯胺(TMB)显色对HCV进行基因分型,根据显色位置做出判断。通过测序验证该新方法的可靠性。采用实时荧光定量(FQ)-PCR法检测血清中HCV RNA水平。应用该方法对佛山地区60份FQ-PCR阳性的HCV血清进行基因分型。
60份血清均通过PCR-RBD成功进行基因分型。发现50例(83.3%)为1b基因型,2例(3.3%)为1a基因型,2例(3.3%)为2a基因型,5例(8.0%)为1a和1b基因型混合,1例(1.7%)为1b和2a基因型混合。未发现2b、3a和3b基因型。PCR-RDB基因分型方法结果与序列分析相符。
新建立的HCV基因分型系统具有灵敏、特异、准确、经济等特点,适用于临床和流行病学研究。HCV基因分型结果显示,1b基因型是佛山地区的主要基因型。